FDA considering banning CCSVI treatment

[Guest guest]

Thursday May 10 , 2012

FDA Warns About Controversial MS Therapy

WASHINGTON -- The FDA has issued an alert about risks, including death,

associated with treatment of chronic cerebrospinal venous insufficiency (CCSVI),

which some believe causes or exacerbates multiple sclerosis.

[Guest guest]

ridiculous!!Thank God I come from a country which enjoys (or used to anyway

before having a horrid female PM - ugh!) being rebellious and holding up its

middle finger to 'authority'! ;)She'll be rite mate!

'What we do in life, echoes through eternity.'

MARCUS AURELIUS (121 - 180 A.D.)

To: mscured

From: berniew1@...

Date: Thu, 10 May 2012 10:46:34 -0400

Subject: FDA considering banning CCSVI treatment

Thursday May 10 , 2012

FDA Warns About Controversial MS Therapy

WASHINGTON -- The FDA has issued an alert about risks, including death,

associated with treatment of chronic cerebrospinal venous insufficiency (CCSVI),

which some believe causes or exacerbates multiple sclerosis.

[Guest guest]

Whoa!!! Can you send the link to this article? I only received the first

sentence. Is there more to the article?

Thanks,

Larry

On Thu, May 10, 2012 at 10:46 AM, BERNARD WINDHAM

wrote:

> **

>

>

>

> Thursday May 10 , 2012

>

>

>

> FDA Warns About Controversial MS Therapy

> WASHINGTON -- The FDA has issued an alert about risks, including death,

> associated with treatment of chronic cerebrospinal venous insufficiency

> (CCSVI), which some believe causes or exacerbates multiple sclerosis.

>

>

[Guest guest]

An interm report was released at the 37th Annual Meeting of the Society of

Interventional Radiologiy. The subject was a CCSVI Clinical Trial involving 213

individuals in Albany NY which found 95% of MS patients had venous obstructions.

One comment made by Dr. Ferral,. an Interventional Radiologist:. " ... for

people with MS who experience debilitating symptoms, minimally invasive

interventional radiology treatments (CCSVI) can be an effective, palliative

treatment that also may improve their quality of life, " .

http://ccsvi-ms.ning.com/profiles/blogs/short-term-outcomes-after-endovascular-t\

reatment-for-chronic

Jorj

FDA considering banning CCSVI treatment

Thursday May 10 , 2012

FDA Warns About Controversial MS Therapy

WASHINGTON -- The FDA has issued an alert about risks, including death,

associated with treatment of chronic cerebrospinal venous insufficiency (CCSVI),

which some believe causes or exacerbates multiple sclerosis.